M. M. Abbass, N. S. Korany, A. H. Salama, J. J. Dmytryk, and B. Safiejko-mroczka, The relationship between receptor for advanced glycation end products expression and the severity of periodontal disease in the gingiva of diabetic and non diabetic periodontitis patients, Arch Oral Biol, vol.57, issue.10, pp.1342-1354, 2012.

S. Amar, N. Gokce, S. Morgan, M. Loukideli, T. E. Van-dyke et al., Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation, Arterioscler Thromb Vasc Biol, vol.23, issue.7, pp.1245-1249, 2003.

G. C. Armitage, Development of a classification system for periodontal diseases and conditions, Ann Periodontol, vol.4, issue.1, pp.1-6, 1999.

J. D. Beck and S. Offenbacher, Systemic effects of periodontitis: epidemiology of periodontal disease and cardiovascular disease, J Periodontol, vol.76, issue.11, pp.2089-2100, 2005.

A. Bierhaus, P. M. Humpert, M. Morcos, T. Wendt, T. Chavakis et al., Understanding RAGE, the receptor for advanced glycation end products, J Mol Med (Berl), vol.83, issue.11, pp.876-886, 2005.

W. S. Borgnakke, P. V. Ylostalo, G. W. Taylor, and R. J. Genco, Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence, J Clin Periodontol, vol.40, pp.135-152, 2013.

P. Boschetto, I. Campo, M. Stendardo, E. Casimirri, C. Tinelli et al., Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD, Eur J Clin Invest, vol.43, issue.6, pp.562-569, 2013.

P. Bouchard, Parodontologie et Dentisterie Implantaire, 2015.

P. Bouchard, M. C. Carra, A. Boillot, F. Mora, and H. Range, Risk factors in periodontology: a conceptual framework, J Clin Periodontol, 2016.

J. Brett, A. M. Schmidt, S. D. Yan, Y. S. Zou, E. Weidman et al., Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues, Am J Pathol, vol.143, issue.6, pp.1699-1712, 1993.

B. Burt, Position paper: epidemiology of periodontal diseases, J Periodontol, vol.76, issue.8, pp.1406-1419, 2005.

M. Catalano, A. Cortelazzo, R. Santi, L. Contino, M. Demicheli et al., The Pro12Ala polymorphism of peroxisome proliferatoractivated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease, Clin Biochem, vol.41, issue.12, pp.981-985, 2008.

M. Challier, S. Jacqueminet, O. Benabdesselam, A. Grimaldi, and J. L. Beaudeux, Increased serum concentrations of soluble receptor for advanced glycation endproducts in patients with type 1 diabetes, Clin Chem, vol.51, issue.9, pp.1749-1750, 2005.

P. C. Chang, L. Y. Chien, L. Y. Chong, Y. P. Kuo, and J. K. Hsiao, Glycated matrix upregulates inflammatory signaling similarly to Porphyromonas gingivalis lipopolysaccharide, J Periodontal Res, vol.48, issue.2, pp.184-193, 2013.

T. Chavakis, A. Bierhaus, N. Al-fakhri, D. Schneider, S. Witte et al., The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment, J Exp Med, vol.198, issue.10, pp.1507-1515, 2003.

Y. Chen, S. S. Yan, J. Colgan, H. P. Zhang, J. Luban et al., Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products, J Immunol, vol.173, issue.2, pp.1399-1405, 2004.

B. Chiu, Multiple infections in carotid atherosclerotic plaques, Am Heart J, vol.138, issue.5, pp.534-536, 1999.

Y. K. Chuah, R. Basir, H. Talib, T. H. Tie, and N. Nordin, Receptor for advanced glycation end products and its involvement in inflammatory diseases, Int J Inflam, p.403460, 2013.

M. M. Cohen and . Jr, Perspectives on RAGE signaling and its role in cardiovascular disease, Am J Med Genet A, vol.161, issue.11, pp.2750-2755, 2013.

F. O. Correa, D. Goncalves, C. M. Figueredo, A. S. Bastos, A. Gustafsson et al., Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes, J Clin Periodontol, vol.37, issue.1, pp.53-58, 2010.

F. O. Costa, L. O. Miranda-cota, E. J. Pereira-lages, A. M. Soares-dutra, P. A. Oliveira et al., Progression of periodontitis and tooth loss associated with glycemic control in individuals undergoing periodontal maintenance therapy: a 5-year follow-up study, J Periodontol, vol.84, issue.5, pp.595-605, 2013.

F. D'aiuto, D. Ready, and M. S. Tonetti, Periodontal disease and C-reactive proteinassociated cardiovascular risk, J Periodontal Res, vol.39, issue.4, pp.236-241, 2004.

G. Daffu, C. H. Del-pozo, K. M. Shea, R. Ananthakrishnan, R. Ramasamy et al., Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond, Int J Mol Sci, vol.14, issue.10, pp.19891-19910, 2013.

M. Dalal, R. D. Semba, K. Sun, C. Crasto, R. Varadhan et al., Endogenous secretory receptor for advanced glycation end products and chronic kidney disease in the elderly population, Am J Nephrol, vol.33, issue.4, pp.313-318, 2011.

C. G. Daly, D. H. Mitchell, J. E. Highfield, D. E. Grossberg, and D. Stewart, Bacteremia due to periodontal probing: a clinical and microbiological investigation, J Periodontol, vol.72, issue.2, pp.210-214, 2001.

R. H. Davenport, D. M. Jr, T. M. Simpson, and . Hassell, Histometric comparison of active and inactive lesions of advanced periodontitis, J Periodontol, vol.53, issue.5, pp.285-295, 1982.

F. Destefano, R. F. Anda, H. S. Kahn, D. F. Williamson, and C. M. Russell, Dental disease and risk of coronary heart disease and mortality, Bmj, vol.306, issue.6879, pp.688-691, 1993.

L. Detzen, S. C. Chen, B. Cheng, P. N. Papapanou, and E. Lalla, Increased levels of soluble CD163 in periodontitis patients, J Clin Periodontol, vol.44, issue.6, pp.585-590, 2017.

R. Donato, B. R. Cannon, G. Sorci, F. Riuzzi, K. Hsu et al., Functions of S100 proteins, Curr Mol Med, vol.13, issue.1, pp.24-57, 2013.

N. Ebe, M. Hara-yokoyama, K. Iwasaki, S. Iseki, S. Okuhara et al., Pocket epithelium in the pathological setting for HMGB1 release, J Dent Res, vol.90, issue.2, pp.235-240, 2011.

P. I. Eke, B. A. Dye, L. Wei, G. O. Thornton-evans, and R. J. Genco, Prevalence of periodontitis in adults in the United States: 2009 and 2010, J Dent Res, vol.91, issue.10, pp.914-920, 2012.

P. I. Eke, R. C. Page, L. Wei, G. Thornton-evans, and R. J. Genco, Update of the case definitions for population-based surveillance of periodontitis, J Periodontol, vol.83, issue.12, pp.1449-1454, 2012.

E. Emanuele, A. Angelo, C. Tomaino, G. Binetti, R. Ghidoni et al., Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia, Arch Neurol, vol.62, issue.11, pp.1734-1736, 2005.

S. Engebretson, R. Chertog, A. Nichols, J. Hey-hadavi, R. Celenti et al., Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes, J Clin Periodontol, vol.34, issue.1, pp.18-24, 2007.

C. Falcone, E. Emanuele, A. Angelo, M. P. Buzzi, C. Belvito et al., Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men, Arterioscler Thromb Vasc Biol, vol.25, issue.5, pp.1032-1037, 2005.

K. Feghali, K. Iwasaki, K. Tanaka, M. Komaki, M. Machigashira et al., Human gingival fibroblasts release high-mobility group box-1 protein through active and passive pathways, Oral Microbiol Immunol, vol.24, issue.4, pp.292-298, 2009.

M. I. Fredriksson, C. M. Figueredo, A. Gustafsson, K. G. Bergstrom, and B. E. Asman, Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins, J Periodontol, vol.70, issue.11, pp.1355-1360, 1999.

V. Fuster and R. Vedanthan, Cardiovascular disease and the UN Millennium Development Goals: time to move forward, Nat Clin Pract Cardiovasc Med, vol.5, issue.10, p.593, 2008.

R. J. Genco and W. S. Borgnakke, Risk factors for periodontal disease, Periodontol, vol.62, issue.1, pp.59-94, 2000.

D. Geroldi, C. Falcone, E. Emanuele, A. Angelo, M. Calcagnino et al., Decreased plasma levels of soluble receptor for advanced glycation endproducts in patients with essential hypertension, J Hypertens, vol.23, issue.9, pp.1725-1729, 2005.

W. V. Giannobile, Salivary diagnostics for periodontal diseases, J Am Dent Assoc, vol.143, pp.6-11, 2010.

I. Gonzalez, J. Romero, B. L. Rodriguez, R. Perez-castro, and A. Rojas, The immunobiology of the receptor of advanced glycation end-products: trends and challenges, Immunobiology, vol.218, issue.5, pp.790-797, 2013.

M. T. Goova, J. Li, T. Kislinger, W. Qu, Y. Lu et al.,

D. M. Yan, A. M. Stern, and . Schmidt, Blockade of receptor for advanced glycation endproducts restores effective wound healing in diabetic mice, Am J Pathol, vol.159, issue.2, pp.513-525, 2001.

N. Grossin, M. P. Wautier, T. Meas, P. J. Guillausseau, P. Massin et al., Severity of diabetic microvascular complications is associated with a low soluble RAGE level, Diabetes Metab, vol.34, issue.4, pp.392-395, 2008.

B. D. Group, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Clin Pharmacol Ther, vol.69, issue.3, pp.89-95, 2001.

G. Hajishengallis, Periodontitis: from microbial immune subversion to systemic inflammation, Nat Rev Immunol, vol.15, issue.1, pp.30-44, 2015.

V. I. Haraszthy, J. J. Zambon, M. Trevisan, M. Zeid, and R. J. Genco, Identification of periodontal pathogens in atheromatous plaques, J Periodontol, vol.71, issue.10, pp.1554-1560, 2000.

M. A. Hofmann, S. Drury, C. Fu, W. Qu, A. Taguchi et al., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides, Cell, vol.97, issue.7, pp.889-901, 1999.

M. A. Hofmann, S. Drury, B. I. Hudson, M. R. Gleason, W. Qu et al., RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response, Genes Immun, vol.3, issue.3, pp.123-135, 2002.

L. I. Holla, K. Kankova, A. Fassmann, D. Buckova, T. Halabala et al., Distribution of the receptor for advanced glycation end products gene polymorphisms in patients with chronic periodontitis: a preliminary study, J Periodontol, vol.72, issue.12, pp.1742-1746, 2001.

J. S. Huang, J. Y. Guh, H. C. Chen, W. C. Hung, Y. H. Lai et al., Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGEinduced collagen production in NRK-49F cells, J Cell Biochem, vol.81, issue.1, pp.102-113, 2001.

B. I. Hudson, A. M. Carter, E. Harja, A. Z. Kalea, M. Arriero et al., Identification, classification, and expression of RAGE gene splice variants, FASEB J, vol.22, issue.5, pp.1572-1580, 2008.

P. P. Hujoel, M. Drangsholt, C. Spiekerman, and N. S. Weiss, An exploration of the periodontitis-cancer association, Ann Epidemiol, vol.13, issue.5, pp.312-316, 2003.

P. P. Hujoel, B. A. White, R. I. Garcia, and M. A. Listgarten, The dentogingival epithelial surface area revisited, J Periodontal Res, vol.36, issue.1, pp.48-55, 2001.

P. M. Humpert, Z. Djuric, S. Kopf, G. Rudofsky, M. Morcos et al., Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes, Cardiovasc Diabetol, vol.6, p.9, 2007.

M. Ide and P. N. Papapanou, Epidemiology of association between maternal periodontal disease and adverse pregnancy outcomes--systematic review, J Periodontol, vol.84, issue.4, pp.181-194, 2013.

Y. Iwamoto, F. Nishimura, M. Nakagawa, H. Sugimoto, K. Shikata et al., The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes, J Periodontol, vol.72, issue.6, pp.774-778, 2001.

A. Jain, E. L. Batista, C. Serhan, G. L. Stahl, and T. E. Van-dyke, Role for periodontitis in the progression of lipid deposition in an animal model, Infect Immun, vol.71, issue.10, pp.6012-6018, 2003.

M. Jimenez, F. B. Hu, M. Marino, Y. Li, and K. J. Joshipura, Type 2 diabetes mellitus and 20 year incidence of periodontitis and tooth loss, Diabetes Res Clin Pract, vol.98, issue.3, pp.494-500, 2012.

N. Kalinina, A. Agrotis, Y. Antropova, G. Divitto, P. Kanellakis et al., Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines, Arterioscler Thromb Vasc Biol, vol.24, issue.12, pp.2320-2325, 2004.

M. Kalousova, M. Hodkova, M. Kazderova, J. Fialova, V. Tesar et al., Soluble receptor for advanced glycation end products in patients with decreased renal function, Am J Kidney Dis, vol.47, issue.3, pp.406-411, 2006.

N. Katakami, M. Matsuhisa, H. Kaneto, T. A. Matsuoka, K. Sakamoto et al., Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications, Diabetes Care, vol.28, issue.11, pp.2716-2721, 2005.

M. Kebschull, R. T. Demmer, and P. N. Papapanou, Gum bug, leave my heart alone!"--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis, J Dent Res, vol.89, issue.9, pp.879-902, 2010.

H. Koyama, T. Shoji, H. Yokoyama, K. Motoyama, K. Mori et al., Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis, Arterioscler Thromb Vasc Biol, vol.25, issue.12, pp.2587-2593, 2005.

E. V. Kozarov, B. R. Dorn, C. E. Shelburne, W. A. Dunn, J. et al., Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis, Arterioscler Thromb Vasc Biol, vol.25, issue.3, pp.17-18, 2005.

M. Kubista, J. M. Andrade, M. Bengtsson, A. Forootan, J. Jonak et al., The real-time polymerase chain reaction, Mol Aspects Med, vol.27, issue.2-3, pp.95-125, 2006.

E. Lalla, C. Kunzel, S. Burkett, B. Cheng, and I. B. Lamster, Identification of unrecognized diabetes and pre-diabetes in a dental setting, J Dent Res, vol.90, issue.7, pp.855-860, 2011.

E. Lalla, I. B. Lamster, M. Feit, L. Huang, A. Spessot et al., Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice, J Clin Invest, vol.105, issue.8, pp.1117-1124, 2000.

E. Lalla and P. N. Papapanou, Diabetes mellitus and periodontitis: a tale of two common interrelated diseases, Nat Rev Endocrinol, vol.7, issue.12, pp.738-748, 2011.

N. Lang, P. M. Bartold, M. Cullinan, M. Jeffcoat, A. Mombelli et al., Consensus Report: Aggressive Periodontitis, vol.4, pp.53-53, 1999.

D. F. Lappin, B. Eapen, D. Robertson, J. Young, and P. J. Hodge, Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus, J Clin Periodontol, vol.36, issue.8, pp.634-641, 2009.

E. J. Lee and J. H. Park, Receptor for Advanced Glycation Endproducts (RAGE), Its Ligands, and Soluble RAGE: Potential Biomarkers for Diagnosis and Therapeutic Targets for Human Renal Diseases, Genomics Inform, vol.11, issue.4, pp.224-229, 2013.

Y. L. Lee, H. Y. Hu, N. Huang, D. K. Hwang, P. Chou et al., Dental prophylaxis and periodontal treatment are protective factors to ischemic stroke, Stroke, vol.44, issue.4, pp.1026-1030, 2013.

J. Li and A. M. Schmidt, Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products, J Biol Chem, vol.272, issue.26, pp.16498-16506, 1997.

A. K. Liew, N. Punnanithinont, Y. C. Lee, and J. Yang, Effect of non-surgical periodontal treatment on HbA1c: a meta-analysis of randomized controlled trials, Aust Dent J, vol.58, issue.3, pp.350-357, 2013.

B. Liliensiek, M. A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper et al., Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response, J Clin Invest, vol.113, issue.11, pp.1641-1650, 2004.

H. Loe, Periodontal disease. The sixth complication of diabetes mellitus, Diabetes Care, vol.16, issue.1, pp.329-334, 1993.

B. G. Loos, Systemic markers of inflammation in periodontitis, J Periodontol, vol.76, issue.11, pp.2106-2115, 2005.

J. Lu, R. Kobayashi, and S. J. Brill, Characterization of a high mobility group 1/2 homolog in yeast, J Biol Chem, vol.271, issue.52, pp.33678-33685, 1996.

L. Luo, P. Xie, P. Gong, X. H. Tang, Y. Ding et al., Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis, Arch Oral Biol, vol.56, issue.10, pp.1106-1111, 2011.

W. Ma, V. Rai, B. I. Hudson, F. Song, A. M. Schmidt et al., RAGE binds C1q and enhances C1q-mediated phagocytosis, Cell Immunol, vol.274, issue.1-2, pp.72-82, 2012.

H. Maillard-lefebvre, E. Boulanger, M. Daroux, C. Gaxatte, B. I. Hudson et al., Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases, Rheumatology (Oxford), vol.48, issue.10, pp.1190-1196, 2009.

B. Maity, D. Sheff, and R. A. Fisher, Immunostaining: detection of signaling protein location in tissues, cells and subcellular compartments, Methods Cell Biol, vol.113, pp.81-105, 2013.

M. Manouchehr-pour, P. J. Spagnuolo, H. M. Rodman, and N. F. Bissada, Impaired neutrophil chemotaxis in diabetic patients with severe periodontitis, J Dent Res, vol.60, issue.3, pp.729-730, 1981.

C. Mattout, D. Bourgeois, and P. Bouchard, Type 2 diabetes and periodontal indicators: epidemiology in France 2002-2003, J Periodontal Res, vol.41, issue.4, pp.253-258, 2006.

J. H. Meurman, M. Sanz, and S. J. Janket, Oral health, atherosclerosis, and cardiovascular disease, Crit Rev Oral Biol Med, vol.15, issue.6, pp.403-413, 2004.

Y. Morimoto, K. I. Kawahara, S. Tancharoen, K. Kikuchi, T. Matsuyama et al., Tumor necrosis factor-alpha stimulates gingival epithelial cells to release high mobility-group box 1, J Periodontal Res, vol.43, issue.1, pp.76-83, 2008.

Y. Morimoto-yamashita, T. Ito, K. Kawahara, K. Kikuchi, S. Tatsuyama-nagayama et al., Periodontal disease and type 2 diabetes mellitus: is the HMGB1-RAGE axis the missing link?, Med Hypotheses, vol.79, issue.4, pp.452-455, 2012.

K. B. Mullis and F. A. Faloona, Specific synthesis of DNA in vitro via a polymerasecatalyzed chain reaction, Methods Enzymol, vol.155, pp.335-350, 1987.

M. Neeper, A. M. Schmidt, J. Brett, S. D. Yan, F. Wang et al., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins, J Biol Chem, vol.267, issue.21, pp.14998-15004, 1992.

G. D. Norata, K. Garlaschelli, L. Grigore, G. Tibolla, S. Raselli et al., Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population, Nutr Metab Cardiovasc Dis, vol.19, issue.2, pp.129-134, 2009.

R. C. Page, Host response tests for diagnosing periodontal diseases, J Periodontol, vol.63, issue.4, pp.356-366, 1992.

R. C. Page and K. S. Kornman, The pathogenesis of human periodontitis: an introduction, Periodontol, vol.14, pp.9-11, 1997.

C. C. Pontes-andersen, A. Flyvbjerg, K. Buschard, and P. Holmstrup, Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats, J Periodontol, vol.78, issue.3, pp.559-565, 2007.

A. R. Pradeep, S. S. Martande, S. P. Singh, D. K. Suke, A. P. Raju et al., Correlation of human S100A12 (EN-RAGE) and high-sensitivity C-reactive protein as gingival crevicular fluid and serum markers of inflammation in chronic periodontitis and type 2 diabetes, Inflamm Res, vol.63, issue.4, pp.317-323, 2014.

C. Prasad, F. V.-imrhan, S. Marotta, P. Juma, and . Vijayagopal, Lifestyle and Advanced Glycation End Products (AGEs) Burden: Its Relevance to Healthy Aging, Aging Dis, vol.5, issue.3, pp.212-217, 2014.

R. Pullerits, M. Bokarewa, L. Dahlberg, and A. Tarkowski, Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control, Arthritis Res Ther, vol.7, issue.4, pp.817-824, 2005.

V. Rai, F. Toure, S. Chitayat, R. Pei, F. Song et al., Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling, J Exp Med, vol.209, issue.13, pp.2339-2350, 2012.

N. S. Ramamurthy and L. M. Golub, Diabetes increases collagenase activity in extracts of rat gingiva and skin, J Periodontal Res, vol.18, issue.1, pp.23-30, 1983.

R. Ramasamy, S. J. Vannucci, S. S. Yan, K. Herold, S. F. Yan et al., Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation, Glycobiology, vol.15, issue.7, pp.16-28, 2005.

R. Ramasamy, S. F. Yan, and A. M. Schmidt, The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes, Vascul Pharmacol, vol.57, issue.5-6, pp.160-167, 2012.

J. Ribeiro, A. Leao, and A. B. Novaes, Periodontal infection as a possible severity factor for rheumatoid arthritis, J Clin Periodontol, vol.32, issue.4, pp.412-416, 2005.

T. Saito, Y. Shimazaki, Y. Kiyohara, I. Kato, M. Kubo et al., The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study, J Dent Res, vol.83, issue.6, pp.485-490, 2004.

T. Sakaguchi, S. F. Yan, S. D. Yan, D. Belov, L. L. Rong et al., Central role of RAGE-dependent neointimal expansion in arterial restenosis, J Clin Invest, vol.111, issue.7, pp.959-972, 2003.

F. Santilli, L. Bucciarelli, D. Noto, A. B. Cefalu, V. Davi et al., Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins, Free Radic Biol Med, vol.43, issue.9, pp.1255-1262, 2007.

C. F. Santos, V. T. Sakai, M. A. Machado, D. N. Schippers, and A. S. Greene, Reverse transcription and polymerase chain reaction: principles and applications in dentistry, J Appl Oral Sci, vol.12, issue.1, pp.1-11, 2004.

V. R. Santos, J. A. Lima, T. E. Goncalves, M. F. Bastos, L. C. Figueiredo et al., Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes, J Periodontol, vol.81, issue.10, pp.1455-1465, 2010.

N. Sasaki, M. Takeuchi, H. Chowei, S. Kikuchi, Y. Hayashi et al., Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques, Neurosci Lett, vol.326, issue.2, pp.117-120, 2002.

T. Sasaki, N. S. Ramamurthy, Z. Yu, and L. M. Golub, Tetracycline administration increases protein (presumably procollagen) synthesis and secretion in periodontal ligament fibroblasts of streptozotocin-induced diabetic rats, J Periodontal Res, vol.27, issue.6, pp.631-639, 1992.

F. A. Scannapieco, Role of oral bacteria in respiratory infection, J Periodontol, vol.70, issue.7, pp.793-802, 1999.

J. H. Schefe, K. E. Lehmann, I. R. Buschmann, T. Unger, and H. Funke-kaiser, Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula, J Mol Med (Berl), vol.84, issue.11, pp.901-910, 2006.

C. Schlueter, S. Hauke, A. M. Flohr, P. Rogalla, and J. Bullerdiek, Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?, Biochim Biophys Acta, vol.1630, issue.1, pp.1-6, 2003.

A. M. Schmidt, M. Vianna, M. Gerlach, J. Brett, J. Ryan et al., Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface, J Biol Chem, vol.267, issue.21, pp.14987-14997, 1992.

A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses, J Clin Invest, vol.108, issue.7, pp.949-955, 2001.

K. Shah and P. Maghsoudlou, Enzyme-linked immunosorbent assay (ELISA): the basics, Br J Hosp Med (Lond), vol.77, issue.7, pp.98-101, 2016.

S. E. Shoelson, J. Lee, and A. B. Goldfine, Inflammation and insulin resistance, J Clin Invest, vol.116, issue.7, pp.1793-1801, 2006.

T. C. Simpson, I. Needleman, S. H. Wild, D. R. Moles, and E. J. Mills, Treatment of periodontal disease for glycaemic control in people with diabetes, Cochrane Database Syst Rev, issue.5, p.4714, 2010.

D. M. Steel and A. S. Whitehead, The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein, Immunol Today, vol.15, issue.2, pp.81-88, 1994.

K. Sugaya, T. Fukagawa, K. Matsumoto, K. Mita, E. Takahashi et al., Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3, Genomics, vol.23, issue.2, pp.408-419, 1994.

W. L. Sun, L. L. Chen, S. Z. Zhang, Y. Z. Ren, and G. M. Qin, Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis, Arch Oral Biol, vol.55, issue.12, pp.970-974, 2010.

A. Taguchi, D. C. Blood, G. Toro, A. Canet, D. C. Lee et al., Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases, Nature, vol.405, issue.6784, pp.354-360, 2000.

N. Taniguchi, K. Kawahara, K. Yone, T. Hashiguchi, M. Yamakuchi et al., , 2003.

G. W. Taylor, B. A. Burt, M. P. Becker, R. J. Genco, M. Shlossman et al., Severe periodontitis and risk for poor glycemic control in patients with non-insulindependent diabetes mellitus, J Periodontol, vol.67, issue.10, pp.1085-1093, 1996.

G. W. Taylor, B. A. Burt, M. P. Becker, R. J. Genco, M. Shlossman et al., Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years, J Periodontol, vol.69, issue.1, pp.76-83, 1998.

S. K. Thoden-van-velzen, L. Abraham-inpijn, and W. R. Moorer, Plaque and systemic disease: a reappraisal of the focal infection concept, J Clin Periodontol, vol.11, issue.4, pp.209-220, 1984.

J. V. Valencia, M. Mone, J. Zhang, M. Weetall, F. P. Buxton et al., Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA, Diabetes, vol.53, issue.3, pp.743-751, 2004.

H. Vlassara and G. E. Striker, AGE restriction in diabetes mellitus: a paradigm shift, Nat Rev Endocrinol, vol.7, issue.9, pp.526-539, 2011.

M. P. Wautier, O. Chappey, S. Corda, D. M. Stern, A. M. Schmidt et al., Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE, Am J Physiol Endocrinol Metab, vol.280, issue.5, pp.685-694, 2001.

T. M. Wendt, N. Tanji, J. Guo, T. R. Kislinger, W. Qu et al.,

A. M. D'agati and . Schmidt, RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy, Am J Pathol, vol.162, issue.4, pp.1123-1137, 2003.

H. Wittkowski, K. Hirono, F. Ichida, T. Vogl, F. Ye et al., Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12, Arthritis Rheum, vol.56, issue.12, pp.4174-4181, 2007.

T. L. Wu, C. C. Tsai, Y. Y. Wang, K. Y. Ho, Y. M. Wu et al., The association between the RAGE G82S polymorphism, sRAGE and chronic periodontitis in Taiwanese individuals with and without diabetes, J Periodontal Res, 2015.

P. Xie, L. X. Deng, P. Gong, Y. Ding, and X. H. Tang, Expression of HMGB1 and HMGN2 in gingival tissues, GCF and PICF of periodontitis patients and peri-implantitis, Braz J Microbiol, vol.42, issue.3, pp.1213-1219, 2011.

S. D. Yan, X. Chen, J. Fu, M. Chen, H. Zhu et al., RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease, Nature, vol.382, issue.6593, pp.685-691, 1996.

S. F. Yan, R. Ramasamy, and A. M. Schmidt, The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature, Circ Res, vol.106, issue.5, pp.842-853, 2010.

S. F. Yan, R. Ramasamy, and A. M. Schmidt, Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging, Biochem Pharmacol, vol.79, issue.10, pp.1379-1386, 2010.

K. Yoshioka, T. Yoshida, Y. Takakura, T. Umekawa, A. Kogure et al., Association study of G1704T and G82S polymorphisms of RAGE gene for microalbuminuria in Japanese type 2 diabetic patients, Metabolism, vol.54, issue.4, pp.488-491, 2005.

S. Yu, H. Li, Y. Ma, and Y. Fu, Matrix metalloproteinase-1 of gingival fibroblasts influenced by advanced glycation end products (AGEs) and their association with receptor for AGEs and nuclear factor-kappaB in gingival connective tissue, J Periodontol, vol.83, issue.1, pp.119-126, 2012.

. Lalla, Increased levels of soluble CD163 in periodontitis patients, J Clin Periodontol, vol.44, issue.6, pp.585-590, 2017.

J. P. Allam, Y. Duan, F. Heinemann, J. Winter, W. Gotz et al., IL-23-producing CD68(+) macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions, Journal of Clinical Periodontology, vol.38, pp.879-886, 2011.

L. P. Aristoteli, H. J. Moller, B. Bailey, S. K. Moestrup, and L. Kritharides, The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis, Atherosclerosis, vol.184, pp.342-347, 2006.

J. Axelsson, H. J. Moller, A. Witasp, A. R. Qureshi, J. J. Carrero et al., Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD, American Journal of Kidney Diseases, vol.48, pp.916-925, 2006.

C. Buechler, K. Eisinger, and S. Krautbauer, Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases, Inflammation & Allergy: Drug Targets, vol.12, pp.391-402, 2013.

A. Droste, C. Sorg, and P. Hogger, Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteinerich family, Biochemical and Biophysical Research Communications, vol.256, pp.110-113, 1999.

A. Etzerodt, M. B. Maniecki, K. Moller, H. J. Moller, and S. K. Moestrup, Tumor necrosis factor alpha-converting enzyme (TACE/ ADAM17) mediates ectodomain shedding of the scavenger receptor CD163, Journal of Leukocyte Biology, vol.88, pp.1201-1205, 2010.

A. Etzerodt and S. K. Moestrup, CD163 and inflammation: Biological, diagnostic, and therapeutic aspects, Antioxidants & Redox Signaling, vol.18, pp.2352-2363, 2013.

B. O. Fabriek, C. D. Dijkstra, . Van-den, and T. K. Berg, The macrophage scavenger receptor CD163, Immunobiology, vol.210, pp.153-160, 2005.

B. O. Fabriek, R. Van-bruggen, D. M. Deng, A. J. Ligtenberg, K. Nazmi et al., The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria, Blood, vol.113, pp.887-892, 2009.

S. Gaini, S. S. Pedersen, O. G. Koldkaer, C. Pedersen, S. K. Moestrup et al., New immunological serum markers in bacteraemia: Anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis, Clinical and Experimental Immunology, vol.151, pp.423-431, 2008.

J. Galea, G. Cruickshank, J. L. Teeling, D. Boche, P. Garland et al., The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage, Journal of Neurochemistry, vol.121, pp.785-792, 2012.

K. F. He, L. Zhang, C. F. Huang, S. R. Ma, Y. F. Wang et al., CD163+ tumor-associated macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carcinoma, BioMed Research International, p.838632, 2014.

S. A. Hienz, S. Paliwal, and S. Ivanovski, Mechanisms of Bone Resorption in Periodontitis, J Immunol Res, p.615486, 2015.

K. A. Hintz, A. J. Rassias, K. Wardwell, M. L. Moss, P. M. Morganelli et al., Endotoxin induces rapid metalloproteinasemediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163, Journal of Leukocyte Biology, vol.72, pp.711-717, 2002.

M. Kebschull, R. T. Demmer, and P. N. Papapanou, Gum bug, leave my heart alone!"-epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis, Journal of Dental Research, vol.89, pp.879-902, 2010.

Y. Komohara, H. Hasita, K. Ohnishi, Y. Fujiwara, S. Suzu et al., Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma, Cancer Science, vol.102, pp.1424-1431, 2011.

Y. Komohara, M. Jinushi, and M. Takeya, Clinical significance of macrophage heterogeneity in human malignant tumors, Cancer Science, vol.105, pp.1-8, 2014.

Y. Komohara, D. Niino, Y. Saito, K. Ohnishi, H. Horlad et al., Clinical significance of CD163(+) tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma, Cancer Science, vol.104, pp.945-951, 2013.

A. Konermann, D. Stabenow, P. A. Knolle, S. A. Held, J. Deschner et al., Regulatory role of periodontal ligament fibroblasts for innate immune cell function and differentiation, Innate Immun, vol.18, pp.745-752, 2012.

K. Kowal, R. Silver, E. Slawinska, M. Bielecki, L. Chyczewski et al., CD163 and its role in inflammation, Folia Histochemica et Cytobiologica, vol.49, pp.365-374, 2011.

E. Lalla and P. N. Papapanou, Diabetes mellitus and periodontitis: A tale of two common interrelated diseases, Nature Reviews Endocrinology, vol.7, pp.738-748, 2011.

S. K. Law, K. J. Micklem, J. M. Shaw, X. P. Zhang, Y. Dong et al., A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily, European Journal of Immunology, vol.23, pp.2320-2325, 1993.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2, 2001.

, Method. Methods, vol.25, pp.402-408

N. Matsushita, M. Kashiwagi, R. Wait, R. Nagayoshi, M. Nakamura et al., Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3, Clinical and Experimental Immunology, vol.130, pp.156-161, 2002.

. Detdn-de-a,

H. J. Moller, Soluble CD163, Scandinavian Journal of Clinical and Laboratory Investigation, vol.72, pp.1-13, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01996186

H. J. Moller, K. Hald, and S. K. Moestrup, Characterization of an enzyme-linked immunosorbent assay for soluble CD163, Scandinavian Journal of Clinical and Laboratory Investigation, vol.62, pp.293-299, 2002.

H. J. Moller, P. H. Petersen, L. Rejnmark, and S. K. Moestrup, Biological variation of soluble CD163, Scandinavian Journal of Clinical and Laboratory Investigation, vol.63, pp.15-21, 2003.

H. J. Moller, N. A. Peterslund, J. H. Graversen, and S. K. Moestrup, Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma, Blood, vol.99, pp.378-380, 2002.

J. A. Moreno, T. Dejouvencel, J. Labreuche, D. M. Smadja, M. Dussiot et al., Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, pp.1253-1262, 2010.

D. M. Mosser and J. P. Edwards, Exploring the full spectrum of macrophage activation, Nature Reviews Immunology, vol.8, pp.958-969, 2008.

G. Onofre, M. Kolackova, K. Jankovicova, and J. Krejsek, Scavenger receptor CD163 and its biological functions, Acta Medica, vol.52, pp.57-61, 2009.

A. Piatkowski, G. Grieb, R. Das, A. Bozkurt, D. Ulrich et al., Soluble CD163: A novel biomarker for the susceptibility to sepsis in severe burn injuries, Indian Journal of Plastic Surgery, vol.44, pp.118-124, 2011.

J. Ribeiro, A. Leao, and A. B. Novaes, Periodontal infection as a possible severity factor for rheumatoid arthritis, Journal of Clinical Periodontology, vol.32, pp.412-416, 2005.

F. A. Scannapieco, Role of oral bacteria in respiratory infection, Journal of Periodontology, vol.70, pp.793-802, 1999.

C. Sima and M. Glogauer, Macrophage subsets and osteoimmunology: Tuning of the immunological recognition and effector systems that maintain alveolar bone, Periodontology, vol.63, pp.80-101, 2000.

L. P. Sorensen, T. Parkner, E. Sondergaard, B. M. Bibby, H. J. Moller et al., Visceral obesity is associated with increased soluble CD163 concentration in men with type 2 diabetes mellitus, Endocrine Connection, vol.4, pp.27-36, 2015.

L. Su, L. Feng, C. Liu, Z. Jiang, M. Li et al., Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: A prospective study, BMC Nephrology, p.123, 2012.

M. Timmermann and P. Hogger, Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes, Free Radical Biology and Medicine, vol.39, pp.98-107, 2005.

H. Van-gorp, P. L. Delputte, and H. J. Nauwynck, Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy, Molecular Immunology, vol.47, pp.1650-1660, 2010.

L. K. Weaver, P. A. Pioli, K. Wardwell, S. N. Vogel, and P. M. Guyre, Up-regulation of human monocyte CD163 upon activation of cellsurface Toll-like receptors, Journal of Leukocyte Biology, vol.81, pp.663-671, 2007.

L. Detzen, S. Chen, B. Cheng, P. N. Papapanou, and E. Lalla, Increased levels of soluble CD163 in periodontitis patients, J Clin Periodontol, vol.44, pp.585-590, 2017.

,